Bladder cancer is the most common malignancy of the urinary tract and arising from the
epithelial lining of the urinary bladder. Resistance to cytotoxic therapies is associated with …

Bladder cancer is one of the major causes of cancer‑associated mortality, with a high
incidence. Curcumin, a polyphenol compound extracted from turmeric, has been identified to …

Resistance of bladder cancer to cisplatin is a major obstacle to successful treatment. In the
current study, we investigated the apoptotic effects of curcumin and cisplatin co-treatment in …

Background Cancer chemopreventive agent curcumin has been shown to possess cell
growth inhibition and apoptosis induction properties in several types of cancer. However, the …

Bladder cancer mortality varies between the countries; whereas being highest in Western
countries, it is lowest in Eastern countries, such as India. Cigarette smoking is one of the …

Bladder cancer is one of the leading causes of cancer-related death in the world. Prolonged
exposure to benzidine is a known cause of bladder cancer. Curcumin has been clinically …

Little progress has been made in the last three decades in the treatment of bladder cancer.
Novel agents that are nontoxic and can improve the current standard of care of this disease …

Aim: Curcumin has potent antitumor activity against many types of human cancers. However,
the inhibitory effects and possible mechanisms of curcumin on gallbladder cancer remains …

Bladder cancer is often associated with recurrence and progression to invasive metastatic
disease that have palliative therapeutic options. The use of traditional chemotherapeutic …

Bladder cancer has a considerable morbidity and mortality impact with particularly poor
prognosis. Curcumin has been recently noticed as a polyphenolic compound separated …